Studio Lsd Ipo
Objects of the Issue
Capital Expenditure
Working Capital Requirement
General Corporate Purposes
Studio LSD IPO Review
Canara Bank –
DRChoksey FinServ –
Emkay Global –
Hem Securities –
IDBI Capital –
Marwadi Shares –
Nirmal Bang –
SBICAP Securities –
Sharekhan –
SMC Global –
Sushil Finance –
Swastika Investmart –
Ventura Securities –
Geojit –
Reliance Securities –
Capital Market –
BP Wealth –
ICICIdirect –
Choice Broking –
IPO Lead Managers aka Merchant Bankers
Corpwis Advisors Pvt.Ltd.
Application | Lot Size | Shares | Amount |
Retail Minimum | 2 | 4,000 | ₹2,04,000 |
Retail Maximum | 2 | 4,000 | ₹2,04,000 |
S-HNI Minimum | 3 | 6,000 | ₹3,06,000 |
B-HNI Minimum | 8 | – | ₹- |
IPO Open Date: | August 18, 2025 |
IPO Close Date: | August 20, 2025 |
Basis of Allotment: | August 21, 2025 |
Refunds: | August 22, 2025 |
Credit to Demat Account: | August 22, 2025 |
IPO Listing Date: | August 25, 2025 |
Period Ended | Revenue | Expense | Profit After Tax | Assets |
2022 | ₹14.61 | ₹13.71 | ₹0.91 | ₹4.14 |
2023 | ₹46.71 | ₹43.08 | ₹2.79 | ₹18.16 |
2024 | ₹102.49 | ₹87.83 | ₹10.9 | ₹36.49 |
2025 | ₹105.01 | ₹89.23 | ₹11.67 | ₹46.67 |
KPI | Values |
ROE: | 53.78% |
ROCE: | 57.29% |
EBITDA Margin: | 14.85% |
PAT Margin: | 11.17% |
Debt to equity ratio: | 0.00 |
Earning Per Share (EPS): | ₹2.85 (Basic) |
Price/Earning P/E Ratio: | N/A |
Return on Net Worth (RoNW): | 53.78% |
Net Asset Value (NAV): | ₹6.73 |
Company | EPS | PE Ratio | RoNW % | NAV | Income |
Baweja Studios Limited | 4.49 | 14.83 | 7.97% | 56.44 | – Cr. |
PicturePost Studios Limited | 1.72 | 12.21 | 17.76% | 9.68 | – Cr. |
IPO Open Date: | August 18, 2025 |
IPO Close Date: | August 20, 2025 |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹48 to ₹51 Per Share |
Issue Size: | Approx ₹70.13 Crores |
Fresh Issue: | Approx ₹56.10 Crores |
Offer for Sale: | Approx 27,50,000 Equity Shares |
Lot Size: | 2,000 Shares |
Issue Type: | Book Build Issue |
IPO Listing: | NSE SME |
Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Anchor Investors List: | Click Here |